Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03314948 · ClinicalTrials.gov registry record
Ultrasound-Guided Costoclavicular Block in Patients With a BMI > 30
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03314948: Clinical Trial study, sponsored by Mayo Clinic.
NCT03314948 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03314948 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The Researchers are trying to determine if Costoclavicular brachial plexus block (CCBPB) can be successfully performed in patients with a body mass index greater than thirty.
Primary Outcome
Determine the success rate of the block in patients with body mass index greater than 30. Assess the effectiveness of the block by performing required assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2019-09-15 |
Why NCT03314948 stopped before completion
NCT03314948 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03314948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03314948 about?
NCT03314948 is a clinical study titled "Ultrasound-Guided Costoclavicular Block in Patients With a BMI > 30". The Researchers are trying to determine if Costoclavicular brachial plexus block (CCBPB) can be successfully performed in patients with a body mass index greater than thirty.
What is the current status of trial NCT03314948?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-10-16. Estimated completion is 2019-09-15.
Who is sponsoring clinical trial NCT03314948?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI